Abstract
Mesenchymal stem cells (MSCs) have been extensively used in both preclinical and clinical studies for a variety of diseases and injury. Accumulating evidence indicates that paracrine function through their secretomes is considered one of the primary attributes for MSC-mediated repair and regeneration. Secretomes from MSCs include both soluble factors and factors released within extracellular vesicles (EVs). Within EVs there are selective subsets of proteins, lipids, and nucleic acids that can modulate recipient cells and disease microenvironments. In this review, we summarize the current understanding of MSC-derived secretomes at molecular and therapeutic levels, focusing on their potential as novel cell-free therapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
